← Back
Data updated: Nov 8, 2026
CMP PHARMA INC
Generics Pharmaceuticals
CMP PHARMA INC is a generic drug manufacturer with 3 FDA-approved products.
1982
Since
3
Drugs
-
Trials
0
New Drugs (2yr)
Modality:
CMP PHARMA INC's Key Drugs
CMP PHARMA INC's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
No active drugs
CMP PHARMA INC's Recent FDA Approvals
New NDA/BLA approvals for CMP PHARMA INC over the last two years — novel drugs only, excluding generics and label supplements.
No recent approvals
CMP PHARMA INC's Therapeutic Areas
Disease areas where CMP PHARMA INC has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.
No indication data
CMP PHARMA INC Pipeline Snapshot
Active clinical trials for CMP PHARMA INC across all therapeutic areas, from ClinicalTrials.gov.
No active pipeline data available
Pro Expected Approvals & Milestones
Loading detailed analysis...
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Active trial monitoring
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Unlock Full Intelligence
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 1982-12-08
- Latest
- 2025-02-05
- Applications
- 3